Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2020

01-08-2020 | Endoscopy | Original Article

Upper Gastrointestinal Disease Influences the Occurrence of Inflammatory Bowel Disease

Authors: Amnon Sonnenberg, Kevin O. Turner, Robert M. Genta

Published in: Digestive Diseases and Sciences | Issue 8/2020

Login to get access

Abstract

Background and Aims

Compromise of the gastric acid barrier may facilitate bacterial invasion of the lower intestinal tract and influence the occurrence of inflammatory bowel disease (IBD). Our study tested the associations between histopathologic changes in the upper and lower gastrointestinal tract in patients undergoing bidirectional endoscopy.

Methods

The Inform Diagnostics database is a national electronic repository of histopathologic records of patients distributed throughout the entire USA. A case–control study among 302,061 patients, of whom 13,943 harbored IBD, evaluated whether the occurrence of Crohn’s disease or ulcerative colitis was influenced by the presence of various upper gastrointestinal diagnoses associated with lowered gastric acid output. The influence of individual risk factors on the occurrence of colonic disease was expressed as odds ratios with their 95% confidence intervals.

Results

The odds ratio for Crohn’s disease being associated with gastric H. pylori was 0.30 (0.24–0.37), with intestinal metaplasia 0.30 (0.24–0.39), with fundic gland polyps 0.42 (0.35–0.50), with gastric hyperplastic polyps 0.35 (0.23–0.51), with Barrett’s metaplasia 0.19 (0.14–0.24), and with reflux esophagitis 0.46 (0.42–0.51). The odds ratio for ulcerative colitis being associated with gastric H. pylori was 0.58 (0.50–0.67), with intestinal metaplasia 0.39 (0.32–0.47), with fundic gland polyps 0.61 (0.53–0.71), with gastric hyperplastic polyps 0.64 (0.49–0.84), with Barrett’s metaplasia 0.50 (0.43–0.59), and with reflux esophagitis 0.77 (0.71–0.84).

Conclusions

A diminished gastric acid barrier function, as evidenced by various upper gastrointestinal diseases associated with lowered gastric acid output, may exert a protective influence against the development of inflammatory bowel disease.
Literature
1.
go back to reference Sonnenberg A, Turner KO, Genta RM. Decreased risk for microscopic colitis and inflammatory bowel disease among patients with reflux disease. Colorectal Dis. 2018;20:813–820.CrossRef Sonnenberg A, Turner KO, Genta RM. Decreased risk for microscopic colitis and inflammatory bowel disease among patients with reflux disease. Colorectal Dis. 2018;20:813–820.CrossRef
2.
go back to reference Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35:469–476.CrossRef Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35:469–476.CrossRef
3.
go back to reference Sonnenberg A, Genta RM. Inverse association between Helicobacter pylori gastritis and microscopic colitis. Inflamm Bowel Dis. 2016;22:182–186.CrossRef Sonnenberg A, Genta RM. Inverse association between Helicobacter pylori gastritis and microscopic colitis. Inflamm Bowel Dis. 2016;22:182–186.CrossRef
4.
go back to reference Graham DY, Opekun AR, Osato MS, et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004;53:1235–1243.CrossRef Graham DY, Opekun AR, Osato MS, et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004;53:1235–1243.CrossRef
5.
go back to reference Ismail-Beigi F, Horton PF, Pope CE 2nd. Histological consequences of gastroesophageal reflux in man. Gastroenterology. 1970;58:163–174.CrossRef Ismail-Beigi F, Horton PF, Pope CE 2nd. Histological consequences of gastroesophageal reflux in man. Gastroenterology. 1970;58:163–174.CrossRef
6.
go back to reference Srivastava A, Odze RD, Lauwers GY, Redston M, Antonioli DA, Glickman JN. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol. 2007;31:1733–1741.CrossRef Srivastava A, Odze RD, Lauwers GY, Redston M, Antonioli DA, Glickman JN. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol. 2007;31:1733–1741.CrossRef
7.
go back to reference Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol. 1996;120:1161–1181.CrossRef Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol. 1996;120:1161–1181.CrossRef
8.
go back to reference Fenoglio-Preiser CM, Noffsinger AE. Gastrointestinal pathology: an atlas and text. 3rd ed. Philadelphia: Wolters Kluwer; 2007:843–847. Fenoglio-Preiser CM, Noffsinger AE. Gastrointestinal pathology: an atlas and text. 3rd ed. Philadelphia: Wolters Kluwer; 2007:843–847.
9.
go back to reference North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Colitis Foundation of America, Bousvaros A, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn’s and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007;44:653–674.CrossRef North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Colitis Foundation of America, Bousvaros A, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn’s and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007;44:653–674.CrossRef
10.
go back to reference Correa P, Cuello C, Duque E. Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J Natl Cancer Inst. 1970;44:297–306.PubMed Correa P, Cuello C, Duque E. Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J Natl Cancer Inst. 1970;44:297–306.PubMed
11.
go back to reference Yao X, Smolka AJ. Gastric parietal cell physiology and Helicobacter pylori-induced disease. Gastroenterology. 2019;156:2158–2173.CrossRef Yao X, Smolka AJ. Gastric parietal cell physiology and Helicobacter pylori-induced disease. Gastroenterology. 2019;156:2158–2173.CrossRef
12.
go back to reference Carmack SW, Genta RM, Schuler CM, Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104:1524–1532.CrossRef Carmack SW, Genta RM, Schuler CM, Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104:1524–1532.CrossRef
13.
go back to reference Genta RM, Schuler CM, Robiou CI, Lash RH. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Clin Gastroenterol Hepatol. 2009;7:849–854.CrossRef Genta RM, Schuler CM, Robiou CI, Lash RH. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Clin Gastroenterol Hepatol. 2009;7:849–854.CrossRef
14.
go back to reference Wang MH, Achkar JP. Gene-environment interactions in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol. 2015;31:277–282.CrossRef Wang MH, Achkar JP. Gene-environment interactions in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol. 2015;31:277–282.CrossRef
15.
go back to reference Serban DE. Microbiota in inflammatory bowel disease pathogenesis and therapy: is it all about diet? Nutr Clin Pract. 2015;30:760–779.CrossRef Serban DE. Microbiota in inflammatory bowel disease pathogenesis and therapy: is it all about diet? Nutr Clin Pract. 2015;30:760–779.CrossRef
16.
go back to reference Cohen LJ, Cho JH, Gevers D, Chu H. Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases. Gastroenterology. 2019;156:2174–2189.CrossRef Cohen LJ, Cho JH, Gevers D, Chu H. Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases. Gastroenterology. 2019;156:2174–2189.CrossRef
17.
go back to reference Sonnenberg A, Turner KO, Genta RM. Associations between gastroesophageal histo-pathology and the occurrence of colon polyps (abstract). Gastroenterology. 2019;156:S683.CrossRef Sonnenberg A, Turner KO, Genta RM. Associations between gastroesophageal histo-pathology and the occurrence of colon polyps (abstract). Gastroenterology. 2019;156:S683.CrossRef
Metadata
Title
Upper Gastrointestinal Disease Influences the Occurrence of Inflammatory Bowel Disease
Authors
Amnon Sonnenberg
Kevin O. Turner
Robert M. Genta
Publication date
01-08-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05972-1

Other articles of this Issue 8/2020

Digestive Diseases and Sciences 8/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.